FDA panel rejects wider use of a Cephalon painkiller
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
FDA panel rejects wider use of a Cephalon painkiller
7 May 08, 08:23
Cephalon Inc., of Frazer, failed to win a federal panel's backing yesterday to expand marketing of its painkiller Fentora to include noncancer patients because of concern that the narcotic would be misused.
more

 

 
© 2007 nafdacnigeria.org